CRMSX
Price
$15.31
Change
+$0.03 (+0.20%)
Updated
Jul 31 closing price
Net Assets
73.2M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

CRMSX vs VSCIX

CRMSX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
CRMSX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRMSX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. CRMSX (73.2M). VSCIX pays higher dividends than CRMSX: VSCIX (1.23) vs CRMSX (0.83). CRMSX was incepted earlier than VSCIX: CRMSX (31 years) vs VSCIX (29 years). CRMSX (1.31) is less costly to investors than VSCIX (0.03). CRMSX is a more actively managed with annual turnover of: 38.00 vs. VSCIX (17.00). CRMSX has a lower initial minimum investment than VSCIX: CRMSX (2500) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. CRMSX (19.94). VSCIX return over 5 years is better than : 35.13 vs. CRMSX (-6.12).
CRMSXVSCIXCRMSX / VSCIX
Total Expense Ratio1.310.034,367%
Annual Report Gross Expense Ratio1.310.034,367%
Fund Existence31 years29 years-
Gain YTD19.79714.591136%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets73.2M189B0%
Annual Yield % from dividends0.831.2367%
Returns for 1 year19.9422.5888%
Returns for 3 years19.8543.4446%
Returns for 5 years-6.1235.13-17%
Returns for 10 years-0.38156.07-0%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFANX14.840.01
+0.07%
Fidelity Asset Manager 40%
EPSPX29.64-0.04
-0.13%
NYLI Epoch Global Equity Yield Class A
MSOIX38.48-0.14
-0.36%
NYLI WMC Enduring Capital Class I
GAGCX38.69-0.17
-0.44%
Gabelli Global Rising Income and Div AAA
MRSRX28.14-0.17
-0.60%
MFS Research International R2